Results 31 to 40 of about 6,318,061 (159)

Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease. [PDF]

open access: yes, 2010
Oxidative stress is common in inflammatory processes associated with many diseases including Chagas' disease. The aim of the present study was to evaluate, in a murine model, biomarkers of oxidative stress together with components of the antioxidant ...
Olindo Assis Martins-Filho   +30 more
core   +1 more source

Research needs for Chagas disease prevention.

open access: yes, 2010
We present an overview of the two main strategies for the primary (vector control) and secondary (patient care) prevention of Chagas disease (CD). We identify major advances, knowledge gaps, and key research needs in both areas.
Santos, Walter S   +7 more
core   +1 more source

Physical activity levels during COVID-19 pandemic and its associated factors in patients with Chagas disease

open access: yesFrontiers in Medicine
BackgroundA better understanding of the consequences of the Coronavirus Disease 2019 (COVID-19) pandemic on lifestyle of patients with Chagas disease (ChD) is of paramount importance to facilitate the implementation of intervention strategies tailored to
Isis Gabrielli Gomes Xavier   +22 more
doaj   +1 more source

Plasma-Derived Extracellular Vesicles as Potential Biomarkers in Heart Transplant Patient with Chronic Chagas Disease [PDF]

open access: yes, 2020
Chagas disease is emerging in countries to which it is not endemic. Biomarkers for earlier therapeutic response assessment in patients with chronic Chagas disease are needed.
Gállego Culleré, M. (Montserrat)   +32 more
core   +1 more source

Chagas disease provider fact sheet [PDF]

open access: yes
What is Chagas disease? -- Where is Chagas found? -- Who is at risk? -- How is the disease transmitted? -- What are the phases of the disease?

core   +2 more sources

Elimination of Chagas disease transmission: perspectives

open access: yesMemorias do Instituto Oswaldo Cruz, 2009
One hundred years after its discovery by Carlos Chagas, American trypanosomiasis, or Chagas disease, remains an epidemiologic challenge. Neither a vaccine nor an ideal specific treatment is available for most chronic cases.
João Carlos Pinto Dias
doaj   +1 more source

Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts

open access: yesTherapeutic Advances in Infectious Disease, 2022
Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF.
Mario J. Olivera   +5 more
doaj   +1 more source

Chagas disease: a report of 17 suspected cases in Japan, 2012–2017

open access: yesTropical Medicine and Health, 2019
Background There are no reports on the prevalence of Chagas disease in Japan. Furthermore, screening programs and access to diagnosis and treatment have not been established.
Kazuo Imai   +12 more
doaj   +1 more source

The chronic gastrointestinal manifestations of Chagas disease

open access: yesClinics, 2009
Chagas disease is an infectious disease caused by the protozoan Trypanosoma cruzi. The disease mainly affects the nervous system, digestive system and heart.
Nilce Mitiko Matsuda   +2 more
doaj   +1 more source

Comparative analysis of health-related fitness in patients with acute versus chronic Chagas disease

open access: yesBiomédica: revista del Instituto Nacional de Salud
Introduction. Although Chagas disease causes high levels of morbidity, the muscle function and tolerance to physical activity in Chagas disease patients are still not completely understood. Objective.
Clara Narcisa Silva Almeida   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy